Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_ffipsc69_promoter_n_PM_14_27_5			1	0.2	4.78E-05	HTR2A	phospholipase C-activating serotonin receptor signaling pathway [BP], 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [MF]
CG_ffipsc69_promoter_n_PM_16_27_19			7	1.0	5.28E-05	LBX1	regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP]
CG_ffipsc69_promoter_n_PM_12_100_11			2	0.4	1.23E-04	TNP1, MBIP	inactivation of MAPK activity involved in osmosensory signaling pathway [BP], chromatin silencing [BP], fertilization, exchange of chromosomal proteins [BP]
CG_ffipsc69_promoter_n_PM_16_51_8			1	0.2	1.03E-04	TAF1C, PARP1, TSC22D1	transcription from RNA polymerase II promoter [BP]
CG_ffipsc69_promoter_n_PM_12_13_5			3	0.6	9.44E-05	LIF	positive regulation of histone H3-K27 acetylation [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], positive regulation of protein localization to nucleus [BP]
CG_ffipsc69_promoter_n_PM_16_3_12			3	0.6	3.80E-05	MYH10	cerebellar Purkinje cell layer development [BP]
CG_ffipsc69_promoter_n_PM_12_99_14			2	0.4	1.57E-04	COL7A1, BUD13	RES complex [CC], collagen type VII [CC]
CG_ffipsc69_promoter_n_PM_14_10_4			1	0.2	1.02E-04	GIP	positive regulation of glucagon secretion [BP]
CG_ffipsc69_promoter_n_PM_12_328_5			2	0.4	4.94E-04	WNT4, SIN3A	positive regulation of aldosterone biosynthetic process [BP], transcription corepressor activity [MF], positive regulation of cortisol biosynthetic process [BP], negative regulation of testosterone biosynthetic process [BP], negative regulation of testicular blood vessel morphogenesis [BP], positive regulation of chromatin silencing [BP], negative regulation of protein localization to nucleus [BP], female sex determination [BP], response to methylglyoxal [BP], negative regulation of male gonad development [BP], renal vesicle induction [BP], negative regulation of histone H3-K27 acetylation [BP], positive regulation of dermatome development [BP], tertiary branching involved in mammary gland duct morphogenesis [BP]
CG_ffipsc69_promoter_n_PM_12_247_7			1	0.2	1.43E-04	SEC13, HLA-DPA1	ER to Golgi transport vesicle membrane [CC]
CG_ffipsc69_promoter_n_PM_12_232_12			4	0.6	3.07E-05	ABR, CARD8, ADIPOR1, SOX10	NACHT domain binding [MF], negative regulation of neutrophil degranulation [BP], extrinsic to mitochondrial outer membrane [CC], identical protein binding [MF]
CG_ffipsc69_promoter_n_PM_12_127_10			2	0.4	2.73E-05	TNPO3	splicing factor protein import into nucleus [BP]
CG_ffipsc69_promoter_n_PM_12_241_9			2	0.4	1.44E-04	WNT4	positive regulation of aldosterone biosynthetic process [BP], thyroid-stimulating hormone-secreting cell differentiation [BP], positive regulation of cortisol biosynthetic process [BP], negative regulation of testosterone biosynthetic process [BP], negative regulation of testicular blood vessel morphogenesis [BP], female sex determination [BP], paramesonephric duct development [BP], renal vesicle induction [BP], negative regulation of male gonad development [BP], positive regulation of dermatome development [BP], tertiary branching involved in mammary gland duct morphogenesis [BP]
CG_ffipsc69_promoter_n_PM_12_101_10			2	0.4	2.23E-05	INTS1	U2 snRNA 3'-end processing [BP]
CG_ffipsc69_promoter_n_PM_16_29_10			4	0.8	3.21E-05	LONP1, RUVBL1, ATXN3, MEAF6	misfolded or incompletely synthesized protein catabolic process [BP], histone H2A acetylation [BP], NuA4 histone acetyltransferase complex [CC]
CG_ffipsc69_promoter_n_PM_16_28_19			7	1.0	2.17E-05	BDH1, ASUN	regulation of fertilization [BP], 3-hydroxybutyrate dehydrogenase activity [MF]
CG_ffipsc69_promoter_n_PM_12_38_5			2	0.4	2.70E-04	LAMTOR1, SLC27A5	cholate-CoA ligase activity [MF], endosome localization [BP]
CG_ffipsc69_promoter_n_PM_14_33_11			2	0.4	4.54E-05	ETNK2, PISD	phosphatidylethanolamine biosynthetic process [BP]
CG_ffipsc69_promoter_n_PM_12_171_8			3	0.6	2.51E-04	CDIPT, PABPC1	negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP], CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_88_7			2	0.4	2.62E-05	TXNDC12	protein-disulfide reductase (glutathione) activity [MF]
CG_ffipsc69_promoter_n_PM_18_10_22			4	0.8	5.26E-05	APPBP2	cytoplasmic vesicle membrane [CC]
CG_ffipsc69_promoter_n_PM_18_12_17			2	0.4	1.03E-04	PHOSPHO1, GRM4	phosphocholine phosphatase activity [MF], phosphoethanolamine phosphatase activity [MF], presynaptic active zone membrane [CC]
CG_ffipsc69_promoter_n_PM_16_20_6			1	0.2	7.00E-05	MRE11A	3'-5' exonuclease activity [MF]
CG_ffipsc69_promoter_n_PM_12_318_5			2	0.4	1.14E-04	PDGFA	regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_ffipsc69_promoter_n_PM_12_315_13			2	0.4	1.22E-04	ASPM	maintenance of centrosome location [BP], negative regulation of asymmetric cell division [BP]
CG_ffipsc69_promoter_n_PM_12_77_6			1	0.2	8.76E-05	APOA2	negative regulation of cholesterol transporter activity [BP]
CG_ffipsc69_promoter_n_PM_12_257_8			1	0.2	3.31E-05	MGAT4B, PSMD5	protein binding involved in protein folding [MF], proteasome regulatory particle assembly [BP], proteasome regulatory particle, base subcomplex [CC], alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_14_47_10			3	0.6	1.12E-04	GIP	positive regulation of glucagon secretion [BP]
CG_ffipsc69_promoter_n_PM_12_63_5			2	0.4	1.10E-04	DPM3, ENTPD5	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP], guanosine-diphosphatase activity [MF]
CG_ffipsc69_promoter_n_PM_12_1_7			3	0.6	9.21E-05	RAB30, MDC1, RSG1, ATE1, RFK, RASL12	FMN biosynthetic process [BP], protein arginylation [BP], arginyltransferase activity [MF], small GTPase mediated signal transduction [BP], FHA domain binding [MF], riboflavin kinase activity [MF], riboflavin biosynthetic process [BP]
CG_ffipsc69_promoter_n_PM_12_44_15			2	0.4	9.60E-05	MAP4, VEGFC	microtubule sliding [BP], positive regulation of lymphangiogenesis [BP]
CG_ffipsc69_promoter_n_PM_12_284_4			2	0.4	3.15E-05	CS, DDB1, SLC35B1	citrate (Si)-synthase activity [MF], UDP-galactose transmembrane transport [BP], Cul4B-RING ubiquitin ligase complex [CC], UDP-galactose transmembrane transporter activity [MF]
CG_ffipsc69_promoter_n_PM_14_66_10			2	0.4	4.05E-05	ESCO1	post-translational protein acetylation [BP]
CG_ffipsc69_promoter_n_PM_16_50_16			4	0.8	1.46E-05	NIN, TMED1, CCT4, STAR, NEK2, MPPE1, DIMT1	centrosome [CC], centrosome-templated microtubule nucleation [BP], microtubule [CC], endoplasmic reticulum-Golgi intermediate compartment [CC], endoplasmic reticulum-Golgi intermediate compartment membrane [CC], cellular response to luteinizing hormone stimulus [BP], 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_123_10			2	0.4	5.31E-05	AVP, BRF1, DGKQ	transcription factor TFIIIB complex [CC], protein kinase C signaling cascade [BP]
CG_ffipsc69_promoter_n_PM_14_15_7			2	0.4	3.31E-05	GBA, PITPNA	phosphatidylcholine transporter activity [MF], sphingosine biosynthetic process [BP], glucosylceramide catabolic process [BP], stearic acid binding [MF], glucosylceramidase activity [MF]
CG_ffipsc69_promoter_n_PM_12_167_16			2	0.4	8.56E-05	RIT1, STRN3	calmodulin binding [MF]
CG_ffipsc69_promoter_n_PM_12_59_14			2	0.4	4.05E-05	PSMB2, SNX5, SRM, NCOR2	macropinocytic cup [CC], extrinsic to internal side of plasma membrane [CC], small molecule metabolic process [BP], regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc69_promoter_n_PM_12_238_7			3	0.6	1.24E-04	INO80	positive regulation of DNA replication involved in S phase [BP]
CG_ffipsc69_promoter_n_PM_14_39_5			3	0.6	1.21E-04	GSK3A, TPT1, BST2, MFSD12	negative regulation of UDP-glucose catabolic process [BP], negative regulation of egress of virus within host cell [BP], transport [BP], negative regulation of plasmacytoid dendritic cell cytokine production [BP], negative regulation of ectoderm development [BP]
CG_ffipsc69_promoter_n_PM_12_253_9			2	0.4	2.79E-04	ANKLE2, SGSH, GFRA4	negative regulation of ossification [BP], mitotic nuclear envelope reassembly [BP], N-sulfoglucosamine sulfohydrolase activity [MF]
CG_ffipsc69_promoter_n_PM_12_125_17			3	0.6	1.17E-05	TNNC1, RLBP1	11-cis retinal binding [MF], regulation of muscle filament sliding speed [BP], troponin T binding [MF]
CG_ffipsc69_promoter_n_PM_12_130_10			2	0.4	1.37E-04	PIF1, TNIP1, MAP3K11	ATP-dependent 5'-3' DNA helicase activity [MF], ATP-dependent 5'-3' DNA/RNA helicase activity [MF], JUN kinase kinase kinase activity [MF], modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade [BP], single-stranded DNA-dependent ATP-dependent DNA helicase activity [MF]
CG_ffipsc69_promoter_n_PM_12_115_5			1	0.2	1.09E-04	COG5	intra-Golgi vesicle-mediated transport [BP]
CG_ffipsc69_promoter_n_PM_12_259_5			2	0.4	1.07E-04	CHRNB4	ligand-gated ion channel activity [MF]
CG_ffipsc69_promoter_n_PM_12_143_8			3	0.6	8.15E-05	CALY	dopamine receptor signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_74_6			2	0.4	5.65E-05	CARD8, ARL3, LMF1	protein secretion [BP], protein glycosylation in Golgi [BP], NACHT domain binding [MF], protein transport [BP], NLRP3 inflammasome complex [CC]
CG_ffipsc69_promoter_n_PM_12_265_9			3	0.6	9.60E-06	TBCC, RP1L1	photoreceptor connecting cilium [CC]
CG_ffipsc69_promoter_n_PM_12_288_9			3	0.4	6.01E-05	ATP2B2, UBD	otolith mineralization [BP], negative regulation of mitotic prometaphase [BP]
CG_ffipsc69_promoter_n_PM_12_158_7			2	0.4	2.80E-04	MTHFR	methylenetetrahydrofolate reductase (NADPH) activity [MF]
CG_ffipsc69_promoter_n_PM_16_21_19			3	0.6	2.77E-05	WASF2, ADRA1D	adenylate cyclase-modulating G-protein coupled receptor signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_14_28_13			4	0.8	9.88E-06	GAMT	guanidinoacetate N-methyltransferase activity [MF], creatine biosynthetic process [BP]
CG_ffipsc69_promoter_n_PM_12_202_10			2	0.4	1.02E-04	YBX2, SLC6A4	negative regulation of cerebellar granule cell precursor proliferation [BP], serotonin:sodium symporter activity [MF], cocaine binding [MF], translational attenuation [BP]
CG_ffipsc69_promoter_n_PM_12_280_9			2	0.4	5.79E-05	DPYD	thymidine catabolic process [BP], dihydropyrimidine dehydrogenase (NADP+) activity [MF]
CG_ffipsc69_promoter_n_PM_12_56_5			1	0.2	5.28E-05	SIK1	negative regulation of CREB transcription factor activity [BP], negative regulation of triglyceride biosynthetic process [BP]
CG_ffipsc69_promoter_n_PM_12_313_6			4	0.8	1.84E-04	TSSK1B, RAB17, CS	immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [BP], citrate (Si)-synthase activity [MF], motile cilium [CC]
CG_ffipsc69_promoter_n_PM_18_23_23			4	0.8	4.56E-05	C5, IL4I1	L-amino-acid oxidase activity [MF], negative regulation of macrophage chemotaxis [BP]
CG_ffipsc69_promoter_n_PM_12_161_9			1	0.2	1.16E-04	PC	pyruvate carboxylase activity [MF]
CG_ffipsc69_promoter_n_PM_18_24_23			3	0.6	5.12E-05	KRAS, DNAH12, DNAH5, RPGRIP1L	cilium axoneme [CC], LRR domain binding [MF]
CG_ffipsc69_promoter_n_PM_12_292_9			3	0.6	2.06E-05	ARNT, KARS	lysyl-tRNA aminoacylation [BP], aryl hydrocarbon receptor activity [MF], lysine-tRNA ligase activity [MF]
CG_ffipsc69_promoter_n_PM_12_45_7			2	0.4	2.33E-04	AMPD1, C1QBP, TAS2R43	bitter taste receptor activity [MF], complement component C1q binding [MF], AMP deaminase activity [MF], positive regulation of mitochondrial translation [BP], mitochondrial ribosome binding [MF], negative regulation of MDA-5 signaling pathway [BP], positive regulation of trophoblast cell migration [BP], kininogen binding [MF], negative regulation of RIG-I signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_242_4			2	0.4	1.29E-04	AKR7A3, STRA6	alveolar primary septum development [BP], vitamin A import [BP], aflatoxin catabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_46_10			4	0.6	1.65E-04	SFRP1, EPB42, QRFP	stromal-epithelial cell signaling involved in prostate gland development [BP], iron ion homeostasis [BP], convergent extension involved in somitogenesis [BP], positive regulation of fibroblast apoptotic process [BP], orexigenic neuropeptide QRFP receptor binding [MF], negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP]
CG_ffipsc69_promoter_n_PM_12_316_8			3	0.6	1.62E-04	CARHSP1, HNRNPD	regulation of mRNA stability [BP]
CG_ffipsc69_promoter_n_PM_12_213_5			1	0.2	3.48E-05	SLC13A4, GLRA1	sodium:sulfate symporter activity [MF], taurine binding [MF], synaptic transmission, glycinergic [BP]
CG_ffipsc69_promoter_n_PM_14_22_7			3	0.6	1.14E-04	KDELR2	KDEL sequence binding [MF]
CG_ffipsc69_promoter_n_PM_16_49_17			3	0.6	1.26E-05	PIR	quercetin 2,3-dioxygenase activity [MF]
CG_ffipsc69_promoter_n_PM_12_261_13			3	0.6	5.33E-05	SLC25A1	mitochondrial citrate transport [BP]
CG_ffipsc69_promoter_n_PM_18_14_46			3	0.6	6.28E-05	PPAP2B, PPP4R1, PPTC7, MTMR10	phosphatase activity [MF], phosphoprotein phosphatase activity [MF]
CG_ffipsc69_promoter_n_PM_12_89_11			3	0.6	5.74E-05	CST3, SORT1, C5, C22orf28	RNA ligase (ATP) activity [MF], negative regulation of blood vessel remodeling [BP], negative regulation of elastin catabolic process [BP], negative regulation of macrophage chemotaxis [BP], neurotensin receptor activity, non-G-protein coupled [MF], negative regulation of histolysis [BP], negative regulation of collagen catabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_300_8			2	0.4	1.02E-04	MAP4K1	MAP kinase kinase kinase kinase activity [MF]
CG_ffipsc69_promoter_n_PM_12_222_12			2	0.4	6.99E-05	MESP1, MTHFR	negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cardiac atrium formation [BP], methylenetetrahydrofolate reductase (NADPH) activity [MF], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], sinus venosus morphogenesis [BP]
CG_ffipsc69_promoter_n_PM_16_26_14			4	0.8	4.20E-06	DCAKD, PPP1R42	manchette [CC], dephospho-CoA kinase activity [MF]
CG_ffipsc69_promoter_n_PM_14_56_9			1	0.2	6.02E-05	SLC15A4	oligopeptide transport [BP]
CG_ffipsc69_promoter_n_PM_12_24_10			3	0.6	1.38E-04	GNE, CH25H, DBN1	cholesterol 25-hydroxylase activity [MF], N-acylmannosamine kinase activity [MF], cell communication by chemical coupling [BP], UDP-N-acetylglucosamine 2-epimerase activity [MF]
CG_ffipsc69_promoter_n_PM_12_293_6			2	0.4	3.15E-05	SACS, AKR7A3	negative regulation of inclusion body assembly [BP], aflatoxin catabolic process [BP]
CG_ffipsc69_promoter_n_PM_14_63_17			4	0.8	4.03E-05	UROS, SIRT3	cellular response to amine stimulus [BP], hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [MF], uroporphyrinogen-III synthase activity [MF]
CG_ffipsc69_promoter_n_PM_12_258_10			3	0.6	1.05E-04	SLC2A5	fructose transmembrane transporter activity [MF], fructose transport [BP]
CG_ffipsc69_promoter_n_PM_12_272_9			3	0.6	1.82E-04	UROS, SRD5A2	uroporphyrinogen III biosynthetic process [BP], cellular response to amine stimulus [BP], sterol 5-alpha reductase activity [MF], uroporphyrinogen-III synthase activity [MF]
CG_ffipsc69_promoter_n_PM_12_204_9			2	0.4	3.78E-05	COQ2, GCSH, INTS4, TUT1	4-hydroxybenzoate decaprenyltransferase activity [MF], glycine decarboxylation via glycine cleavage system [BP], snRNA processing [BP], 4-hydroxybenzoate nonaprenyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_15_11			3	0.6	1.52E-04	SNAPC4	snRNA-activating protein complex [CC], snRNA transcription [BP], snRNA transcription from RNA polymerase III promoter [BP], snRNA transcription from RNA polymerase II promoter [BP]
CG_ffipsc69_promoter_n_PM_16_6_82			6	1.0	7.04E-05	SYMPK, ERCC2, CPSF1, KDM5A, NUDT21	cyclin-dependent protein kinase activating kinase holoenzyme complex [CC], mRNA polyadenylation [BP]
CG_ffipsc69_promoter_n_PM_12_47_9			1	0.2	9.29E-05	FGF10	positive regulation of urothelial cell proliferation [BP], mesenchymal-epithelial cell signaling involved in lung development [BP], secretion by lung epithelial cell involved in lung growth [BP], mammary gland bud formation [BP], positive regulation of hair follicle cell proliferation [BP], urothelial cell proliferation [BP], mesenchymal cell differentiation involved in lung development [BP], tear secretion [BP], semicircular canal fusion [BP], branch elongation involved in salivary gland morphogenesis [BP], fibroblast growth factor receptor signaling pathway involved in mammary gland specification [BP], bronchiole morphogenesis [BP], lung proximal/distal axis specification [BP], submandibular salivary gland formation [BP], positive regulation of white fat cell proliferation [BP], Harderian gland development [BP]
CG_ffipsc69_promoter_n_PM_18_28_33			4	0.8	8.83E-05	GFPT1, ANKLE2, XBP1, BAZ2A	heterochromatin assembly involved in chromatin silencing [BP], serotonin secretion, neurotransmission [BP], glucosamine biosynthetic process [BP], mitotic nuclear envelope reassembly [BP], epithelial cell maturation involved in salivary gland development [BP]
CG_ffipsc69_promoter_n_PM_12_240_9			3	0.6	1.85E-05	MBOAT4, PRKACA	water transport [BP], peptidyl-serine octanoylation [BP], serine O-acyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_14_67_6			2	0.4	1.67E-05	NR0B1	DNA hairpin binding [MF]
CG_ffipsc69_promoter_n_PM_12_179_14			3	0.6	6.41E-05	JAK3, STAR	cellular response to growth hormone stimulus [BP], cellular response to luteinizing hormone stimulus [BP], negative regulation of FasL biosynthetic process [BP], cellular response to alkaloid [BP]
CG_ffipsc69_promoter_n_PM_14_21_20			4	0.6	7.39E-05	GTF2E2, MED1, E2F1, TREH	alpha,alpha-trehalase activity [MF], core promoter binding [MF], trehalose catabolic process [BP], transcription factor TFIIE complex [CC], trehalose metabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_176_11			1	0.2	2.57E-05	TGFB3, SLC13A1	sodium:sulfate symporter activity [MF], ossification involved in bone remodeling [BP], detection of hypoxia [BP]
CG_ffipsc69_promoter_n_PM_18_20_31			4	0.8	3.30E-05	NACA, ROCK2, ATP5B	mitochondrial proton-transporting ATP synthase, catalytic core [CC], negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP], nascent polypeptide-associated complex [CC], positive regulation of centrosome duplication [BP]
CG_ffipsc69_promoter_n_PM_12_317_18			2	0.4	1.95E-04	SLC13A5, MMS19, TMEM86B	succinate transmembrane transporter activity [MF], alkenylglycerophosphocholine hydrolase activity [MF], alkenylglycerophosphoethanolamine hydrolase activity [MF], phosphorelay signal transduction system [BP]
CG_ffipsc69_promoter_n_PM_12_7_14			5	0.8	1.51E-04	MFSD10	tetracycline transporter activity [MF]
CG_ffipsc69_promoter_n_PM_12_65_12			2	0.4	4.91E-05	ATAD1, SLC7A10, GAS6, NTF4	cellular response to vitamin K [BP], memory [BP], sensory organ boundary specification [BP], negative regulation of renal albumin absorption [BP], D-alanine transport [BP], negative regulation of oligodendrocyte apoptotic process [BP]
CG_ffipsc69_promoter_n_PM_12_122_8			1	0.2	2.04E-04	KLF4, CCBL1, UNC13D	glutamine-phenylpyruvate transaminase activity [MF], L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], epidermis morphogenesis [BP], L-glutamine:pyruvate aminotransferase activity [MF], granuloma formation [BP]
CG_ffipsc69_promoter_n_PM_16_1_98			6	1.0	5.96E-05	THY1, SOS1, GMIP, ERRFI1	Rho GTPase activator activity [MF]
CG_ffipsc69_promoter_n_PM_12_177_12			1	0.2	3.31E-05	NMU	neuromedin U receptor binding [MF]
CG_ffipsc69_promoter_n_PM_16_15_28			5	1.0	2.94E-05	GADD45GIP1, FLCN, ADAM17, NAE1	protein complex binding [MF], positive regulation of transforming growth factor beta receptor signaling pathway [BP], cell cycle [BP]
CG_ffipsc69_promoter_n_PM_12_282_19			4	0.8	1.69E-04	MPC1, NKX2-2	ventral spinal cord interneuron fate determination [BP], pancreatic A cell fate commitment [BP], type B pancreatic cell fate commitment [BP], pancreatic PP cell fate commitment [BP], mitochondrial pyruvate transport [BP]
CG_ffipsc69_promoter_n_PM_12_206_8			2	0.4	8.16E-05	WDR47, NINL	microtubule [CC]
CG_ffipsc69_promoter_n_PM_12_119_8			1	0.2	1.99E-04	TTPA, NOX1	response to pH [BP]
CG_ffipsc69_promoter_n_PM_12_109_9			2	0.4	6.38E-05	TMEM173, RAB17, CDIPT, IL12RB1	cyclic-di-GMP binding [MF], immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [BP], interleukin-12 receptor complex [CC], interleukin-12 receptor activity [MF], positive regulation of defense response to virus by host [BP], CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_43_7			2	0.4	9.21E-05	CACNA1S	extraocular skeletal muscle development [BP]
CG_ffipsc69_promoter_n_PM_12_281_6			2	0.4	6.18E-06	CLCF1, ASCL2	CNTFR-CLCF1 complex [CC], CRLF-CLCF1 complex [CC], ciliary neurotrophic factor receptor binding [MF], negative regulation of Schwann cell proliferation [BP], spongiotrophoblast differentiation [BP], positive regulation of isotype switching to IgE isotypes [BP], positive regulation of immunoglobulin production [BP]
CG_ffipsc69_promoter_n_PM_14_58_5			2	0.4	4.56E-05	EIF2AK1, HPX, CPOX	porphyrin-containing compound metabolic process [BP], protoporphyrinogen IX metabolic process [BP], hemoglobin metabolic process [BP], heme metabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_214_7			2	0.4	1.08E-04	FLT4	vascular endothelial growth factor receptor signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_150_6			1	0.2	1.60E-04	AHI1	pronephric nephron tubule morphogenesis [BP], pronephric duct morphogenesis [BP], Kupffer's vesicle development [BP]
CG_ffipsc69_promoter_n_PM_14_77_12			3	0.6	2.18E-05	PYGL	purine nucleobase binding [MF], glycogen phosphorylase activity [MF]
CG_ffipsc69_promoter_n_PM_12_185_8			2	0.4	1.91E-04	TFF3, P2RX1	external side of cell outer membrane [CC], apical lamina of hyaline layer [CC]
CG_ffipsc69_promoter_n_PM_12_326_11			2	0.4	1.64E-05	TAS2R43	bitter taste receptor activity [MF]
CG_ffipsc69_promoter_n_PM_12_249_12			2	0.4	6.90E-05	PROM1, AP3B2	AP-3 adaptor complex [CC], glomerular parietal epithelial cell differentiation [BP], positive regulation of nephron tubule epithelial cell differentiation [BP]
CG_ffipsc69_promoter_n_PM_12_41_7			4	0.8	1.52E-04	NCAPD3, PDGFB	metanephric glomerular endothelium development [BP], metanephric glomerular mesangial cell development [BP], nuclear condensin complex [CC]
CG_ffipsc69_promoter_n_PM_12_62_8			2	0.4	1.38E-04	FOXJ1	glomerular parietal epithelial cell development [BP], negative regulation of humoral immune response mediated by circulating immunoglobulin [BP], positive regulation of central B cell tolerance induction [BP], positive regulation of lung ciliated cell differentiation [BP], central tolerance induction [BP]
CG_ffipsc69_promoter_n_PM_12_200_10			2	0.4	2.10E-04	KATNA1	microtubule-severing ATPase activity [MF], microtubule severing [BP]
CG_ffipsc69_promoter_n_PM_12_3_17			2	0.4	8.25E-05	PKP2	adherens junction maintenance [BP]
CG_ffipsc69_promoter_n_PM_12_165_14			3	0.6	2.03E-04	QRFP	orexigenic neuropeptide QRFP receptor binding [MF]
CG_ffipsc69_promoter_n_PM_12_304_20			3	0.6	1.00E-04	FADS1	C-5 sterol desaturase activity [MF]
CG_ffipsc69_promoter_n_PM_18_22_35			4	0.8	2.98E-05	GFPT2	glutamine-fructose-6-phosphate transaminase (isomerizing) activity [MF]
CG_ffipsc69_promoter_n_PM_12_51_8			2	0.4	1.20E-04	GCH1	GTP cyclohydrolase I activity [MF], 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
CG_ffipsc69_promoter_n_PM_14_44_6			2	0.4	8.07E-05	OAT, DTYMK, NANP	N-acylneuraminate-9-phosphatase activity [MF], ornithine-oxo-acid transaminase activity [MF], nucleoside phosphate kinase activity [MF]
CG_ffipsc69_promoter_n_PM_14_73_13			3	0.6	2.47E-05	SHPK	cellular response to interleukin-13 [BP], sedoheptulokinase activity [MF]
CG_ffipsc69_promoter_n_PM_14_1_19			5	0.8	3.95E-05	CYP39A1, PLA2G16	1-acyl-2-lysophosphatidylserine acylhydrolase activity [MF], steroid 7-alpha-hydroxylase activity [MF], 24-hydroxycholesterol 7alpha-hydroxylase activity [MF], phosphatidylserine 1-acylhydrolase activity [MF]
CG_ffipsc69_promoter_n_PM_16_42_6			1	0.2	3.32E-05	FITM2	integral to endoplasmic reticulum membrane [CC]
CG_ffipsc69_promoter_n_PM_12_236_5			3	0.6	1.02E-04	GMDS	GDP-mannose 4,6-dehydratase activity [MF], NADP+ binding [MF]
CG_ffipsc69_promoter_n_PM_12_195_8			3	0.6	1.09E-04	DBN1	cell communication by chemical coupling [BP], actomyosin [CC]
CG_ffipsc69_promoter_n_PM_12_324_12			1	0.2	2.06E-04	TXNL4A, WNT5A, SRSF1, TXNRD2, VDR	receptor tyrosine kinase-like orphan receptor binding [MF], response to oxygen radical [BP], vitamin D3 receptor activity [MF], spliceosomal complex assembly [BP], mRNA splicing, via spliceosome [BP], RNA splicing, via transesterification reactions [BP]
CG_ffipsc69_promoter_n_PM_12_129_9			1	0.2	1.33E-04	L2HGDH, PGM3, UNC13D	2-hydroxyglutarate dehydrogenase activity [MF], phosphoacetylglucosamine mutase activity [MF], granuloma formation [BP]
CG_ffipsc69_promoter_n_PM_12_103_7			3	0.6	8.31E-05	LBX1, GNE, TK1, BST2, LRP8	ammon gyrus development [BP], negative regulation of plasmacytoid dendritic cell cytokine production [BP], N-acylmannosamine kinase activity [MF], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], negative regulation of egress of virus within host cell [BP], fetal process involved in parturition [BP], UDP-N-acetylglucosamine 2-epimerase activity [MF]
CG_ffipsc69_promoter_n_PM_12_321_7			2	0.4	2.52E-04	IL17B	positive regulation of cytokine production involved in inflammatory response [BP]
CG_ffipsc69_promoter_n_PM_16_24_12			4	0.8	4.55E-05	TJP1	blastocyst formation [BP]
CG_ffipsc69_promoter_n_PM_14_43_9			4	0.8	2.87E-05	SLC30A2, EDEM3	glycoprotein endo-alpha-1,2-mannosidase activity [MF], positive regulation of sequestering of zinc ion [BP]
CG_ffipsc69_promoter_n_PM_12_277_14			2	0.4	4.09E-05	EDN2, ACOX3	hormonal regulation of the force of heart contraction [BP], pristanoyl-CoA oxidase activity [MF]
CG_ffipsc69_promoter_n_PM_12_60_7			4	0.8	6.48E-05	WNT7B, PTCH1	negative regulation of smoothened signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_163_10			2	0.4	3.59E-04	ZNF616, ZNF841, SALL1, CTNND2, ZNF432, ZNF415, ZNF154	transcription, DNA-dependent [BP], DNA binding [MF], inductive cell-cell signaling [BP], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_ffipsc69_promoter_n_PM_12_108_11			2	0.4	2.56E-05	MAGI1, MYO1C	protein C-terminus binding [MF], myosin I complex [CC], stereocilium membrane [CC], positive regulation of vascular endothelial growth factor signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_22_8			4	0.8	1.27E-04	TMEM86B, MTFMT	alkenylglycerophosphocholine hydrolase activity [MF], methionyl-tRNA formyltransferase activity [MF], alkenylglycerophosphoethanolamine hydrolase activity [MF]
CG_ffipsc69_promoter_n_PM_12_156_7			3	0.6	4.60E-05	ADAMTS8	low affinity phosphate transmembrane transporter activity [MF]
CG_ffipsc69_promoter_n_PM_12_31_13			2	0.4	4.89E-05	TXNDC12, CYP3A5	alkaloid catabolic process [BP], protein-disulfide reductase (glutathione) activity [MF]
CG_ffipsc69_promoter_n_PM_16_32_24			3	0.6	2.90E-05	ERO1L, DCTN1, HDGF	endoplasmic reticulum unfolded protein response [BP]
CG_ffipsc69_promoter_n_PM_12_86_6			2	0.4	3.56E-05	CXXC4	zygotic specification of dorsal/ventral axis [BP]
CG_ffipsc69_promoter_n_PM_12_52_9			3	0.6	2.28E-04	GLMN, ALDH1L1, ALDH4A1, NUDT12	hepatocyte growth factor receptor binding [MF], oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [MF], NAD catabolic process [BP], 1-pyrroline-5-carboxylate dehydrogenase activity [MF], NAD+ diphosphatase activity [MF]
CG_ffipsc69_promoter_n_PM_16_38_11			4	0.8	9.89E-05	OCSTAMP, TRIT1	positive regulation of osteoclast proliferation [BP], tRNA dimethylallyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_84_13			2	0.4	6.47E-05	DPH5, RP9	signal recognition particle receptor complex [CC], diphthine synthase activity [MF]
CG_ffipsc69_promoter_n_PM_12_307_5			2	0.4	3.52E-05	ACOX3	pristanoyl-CoA oxidase activity [MF]
CG_ffipsc69_promoter_n_PM_12_320_10			2	0.4	1.20E-04	LIPT2, NGLY1	peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [MF], lipoyl(octanoyl) transferase activity [MF], lipoate biosynthetic process [BP], octanoyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_92_8			2	0.4	8.61E-05	RFX3, AIM2, KIRREL3	principal sensory nucleus of trigeminal nerve development [BP], pyroptosis [BP], type B pancreatic cell maturation [BP]
CG_ffipsc69_promoter_n_PM_14_74_5			3	0.6	2.25E-05	SELE, RASGRP4, SUMO1	activation of phospholipase C activity [BP], protein localization to nuclear pore [BP]
CG_ffipsc69_promoter_n_PM_12_42_4			1	0.2	1.46E-04	MBL2, TNNI3	calcium-dependent protein binding [MF]
CG_ffipsc69_promoter_n_PM_12_57_8			2	0.4	1.05E-04	SLC17A1	sodium-dependent phosphate transport [BP]
CG_ffipsc69_promoter_n_PM_12_64_7			1	0.2	6.10E-05	SLC25A1, BRCA1	positive regulation of histone H4-K20 methylation [BP], positive regulation of histone H3-K9 acetylation [BP], mitochondrial citrate transport [BP], positive regulation of histone H4-K16 acetylation [BP]
CG_ffipsc69_promoter_n_PM_12_297_6			3	0.6	1.08E-04	NAGA, NMU	neuromedin U receptor binding [MF], alpha-N-acetylgalactosaminidase activity [MF]
CG_ffipsc69_promoter_n_PM_12_285_11			2	0.4	1.32E-04	ADPRHL1	protein de-ADP-ribosylation [BP], ADP-ribosylarginine hydrolase activity [MF]
CG_ffipsc69_promoter_n_PM_12_228_11			3	0.6	1.31E-04	EARS2	glutamate-tRNA(Gln) ligase activity [MF], glutamyl-tRNA aminoacylation [BP]
CG_ffipsc69_promoter_n_PM_14_36_5			1	0.2	4.13E-05	SLC45A2	melanosome membrane [CC]
CG_ffipsc69_promoter_n_PM_14_41_6			3	0.6	5.99E-05	C3AR1	C3a anaphylatoxin receptor activity [MF], complement component C3a receptor activity [MF]
CG_ffipsc69_promoter_n_PM_12_172_7			2	0.4	2.10E-05	JAK3, ARSA, AK3	response to interleukin-9 [BP], cerebroside-sulfatase activity [MF], negative regulation of dendritic cell cytokine production [BP], ITP metabolic process [BP], negative regulation of FasL biosynthetic process [BP], nucleoside triphosphate adenylate kinase activity [MF]
CG_ffipsc69_promoter_n_PM_12_187_9			1	0.2	4.72E-05	GALNS, B4GALT3	keratan sulfate metabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_79_15			3	0.6	4.25E-05	NKX2-1	menarche [BP]
CG_ffipsc69_promoter_n_PM_12_27_20			4	0.8	6.73E-05	PRDM5, STK10, HNRNPK, NACC2	polo kinase kinase activity [MF], RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], histone deacetylation [BP], transcription regulatory region sequence-specific DNA binding [MF]
CG_ffipsc69_promoter_n_PM_12_121_7			3	0.6	5.14E-05	SLC17A7, NACC2	sequestering of neurotransmitter [BP], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], sodium:inorganic phosphate symporter activity [MF]
CG_ffipsc69_promoter_n_PM_14_51_7			2	0.4	5.26E-05	ALS2CL, FLOT1, DOK2	Ras protein signal transduction [BP], regulation of Rho protein signal transduction [BP]
CG_ffipsc69_promoter_n_PM_12_76_7			4	0.8	5.78E-05	APRT, SLC25A1, SLC6A4, LSM4	mitochondrial citrate transport [BP], serotonin:sodium symporter activity [MF], U6 snRNP [CC], adenine binding [MF], adenine phosphoribosyltransferase activity [MF], cocaine binding [MF], negative regulation of cerebellar granule cell precursor proliferation [BP]
CG_ffipsc69_promoter_n_PM_14_61_8			3	0.6	2.49E-05	BCDIN3D	RNA methylation [BP], RNA methyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_14_25_12			2	0.4	8.69E-05	NACA	nascent polypeptide-associated complex [CC]
CG_ffipsc69_promoter_n_PM_12_124_10			3	0.6	2.38E-04	ADH4, HHATL	NADPH:quinone reductase activity [MF], benzaldehyde dehydrogenase activity [MF], negative regulation of N-terminal protein palmitoylation [BP], alcohol dehydrogenase activity, zinc-dependent [MF], all-trans retinal binding [MF]
CG_ffipsc69_promoter_n_PM_16_18_10			3	0.6	4.53E-05	PKP2, RANGAP1	positive regulation of Ran GTPase activity [BP], Ran GTPase activator activity [MF], adherens junction maintenance [BP]
CG_ffipsc69_promoter_n_PM_12_90_6			2	0.4	1.14E-04	SLC25A17	FAD transmembrane transporter activity [MF], NAD transporter activity [MF], FMN transmembrane transporter activity [MF], FAD transmembrane transport [BP]
CG_ffipsc69_promoter_n_PM_12_250_10			2	0.4	3.16E-05	CDIPT, SGSH, NOTCH1, CARD9, IL5RA	response to muramyl dipeptide [BP], CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [MF], N-sulfoglucosamine sulfohydrolase activity [MF], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], inflammatory response to antigenic stimulus [BP], regulation of extracellular matrix assembly [BP], venous endothelial cell differentiation [BP]
CG_ffipsc69_promoter_n_PM_12_170_4			1	0.2	4.30E-05	KDM2B, FASN, M6PR, HEY1, RNGTT	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF], atrioventricular valve formation [BP], [acyl-carrier-protein] S-acetyltransferase activity [MF], polynucleotide 5'-phosphatase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], mannose transmembrane transporter activity [MF], mRNA guanylyltransferase activity [MF], initiation of neural tube closure [BP]
CG_ffipsc69_promoter_n_PM_12_69_8			3	0.6	2.68E-05	RUVBL1, PKMYT1, HGF	negative regulation of hydrogen peroxide-mediated programmed cell death [BP], mitosis [BP]
CG_ffipsc69_promoter_n_PM_16_11_45			5	1.0	2.12E-05	GRM6	new growing cell tip [CC]
CG_ffipsc69_promoter_n_PM_12_139_7			3	0.6	2.50E-04	NOTCH1	vasculogenesis involved in coronary vascular morphogenesis [BP], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], coronary vein morphogenesis [BP], regulation of extracellular matrix assembly [BP], venous endothelial cell differentiation [BP], mitral valve formation [BP], growth involved in heart morphogenesis [BP]
CG_ffipsc69_promoter_n_PM_14_79_21			2	0.4	5.47E-05	ARHGEF2, HAUS4	spindle [CC]
CG_ffipsc69_promoter_n_PM_12_126_13			2	0.4	2.63E-05	PRHOXNB	urate catabolic process [BP], allantoin biosynthetic process [BP]
CG_ffipsc69_promoter_n_PM_12_37_6			1	0.2	2.12E-04	DSCAM, DCXR	positive regulation of axon extension involved in axon guidance [BP], D-xylose metabolic process [BP], dendrite self-avoidance [BP], post-embryonic retina morphogenesis in camera-type eye [BP], L-xylulose reductase (NADP+) activity [MF]
CG_ffipsc69_promoter_n_PM_18_2_29			3	0.6	4.50E-05	INPP5K, GSK3A, KIF13A, KIF13B, CCNT1, S100A6, GOPC, ELAVL1	negative regulation of glucose transport [BP], negative regulation of glycogen (starch) synthase activity [BP], axonogenesis [BP], Golgi to plasma membrane transport [BP], negative regulation of glycogen biosynthetic process [BP], regulation of glycogen biosynthetic process [BP], negative regulation of insulin receptor signaling pathway [BP], Golgi to plasma membrane protein transport [BP], protein kinase binding [MF]
CG_ffipsc69_promoter_n_PM_12_198_4			2	0.4	9.87E-05	CTSL2, PITPNA, DEDD, PSG7, MGAT1	stearic acid binding [MF], female pregnancy [BP], decidualization [BP], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_151_6			2	0.4	1.52E-05	AGT, FUCA1, SERPINA11	response to muscle activity involved in regulation of muscle adaptation [BP], positive regulation of extracellular matrix constituent secretion [BP], ovarian follicle rupture [BP], astrocyte activation [BP], negative regulation of endopeptidase activity [BP], acetyltransferase activator activity [MF], alpha-L-fucosidase activity [MF], positive regulation of NAD(P)H oxidase activity [BP], serine-type endopeptidase inhibitor activity [MF], type 2 angiotensin receptor binding [MF], angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure [BP]
CG_ffipsc69_promoter_n_PM_12_183_9			3	0.6	1.43E-04	IRF7	regulation of MyD88-independent toll-like receptor signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_186_5			2	0.4	2.92E-04	CYP51A1, INSRR	cellular response to alkalinity [BP], cholesterol biosynthetic process via 24,25-dihydrolanosterol [BP], sterol 14-demethylase activity [MF]
CG_ffipsc69_promoter_n_PM_14_32_6			2	0.4	3.76E-05	MYBPC3, MYH13	C zone [CC], myofibril [CC], striated muscle myosin thick filament [CC], regulation of muscle filament sliding [BP], myosin filament [CC], muscle myosin complex [CC]
CG_ffipsc69_promoter_n_PM_12_210_14			3	0.6	8.91E-05	HPGD, ALG9	dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF], lipoxygenase pathway [BP], 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [MF], dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_16_14_30			4	0.8	2.97E-05	AGMAT	agmatine biosynthetic process [BP], agmatinase activity [MF], putrescine biosynthetic process from arginine [BP]
CG_ffipsc69_promoter_n_PM_12_223_10			3	0.6	1.83E-04	FECH	detection of UV [BP], ferrochelatase activity [MF], regulation of eIF2 alpha phosphorylation by heme [BP]
CG_ffipsc69_promoter_n_PM_14_64_18			2	0.4	5.27E-05	DACH1, ANKH, AXIN2, COQ3, DOLK	dolichyl monophosphate biosynthetic process [BP], RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity involved in preinitiation complex assembly [MF], 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF], regulation of chondrocyte development [BP], dolichol kinase activity [MF], inorganic diphosphate transmembrane transporter activity [MF], 3-demethylubiquinone-9 3-O-methyltransferase activity [MF], hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_252_14			2	0.4	7.05E-05	GYS1	glycogen (starch) synthase activity [MF]
CG_ffipsc69_promoter_n_PM_12_203_9			1	0.2	7.99E-05	BRF1, RAB17, TWF1	transcription factor TFIIIB complex [CC], regulation of actin phosphorylation [BP], immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [BP]
CG_ffipsc69_promoter_n_PM_14_34_5			4	0.8	3.10E-05	UFSP1, DEFA1B, MCL1, TAT	UFM1 hydrolase activity [MF], protein channel activity [MF], L-tyrosine:2-oxoglutarate aminotransferase activity [MF], azurophil granule lumen [CC]
CG_ffipsc69_promoter_n_PM_12_189_9			3	0.6	1.36E-04	MYH6, HGD	homogentisate 1,2-dioxygenase activity [MF], visceral muscle development [BP]
CG_ffipsc69_promoter_n_PM_12_224_6			1	0.2	1.77E-04	CDK5, CHST6, CHST5	N-acetylglucosamine 6-O-sulfotransferase activity [MF], keratan sulfate metabolic process [BP], keratan sulfate biosynthetic process [BP], N-acetylglucosamine metabolic process [BP], sulfotransferase activity [MF], acetylcholine receptor activator activity [MF]
CG_ffipsc69_promoter_n_PM_12_217_9			4	0.6	4.21E-05	GLDC	glycine dehydrogenase (decarboxylating) activity [MF]
CG_ffipsc69_promoter_n_PM_12_36_12			2	0.4	2.61E-04	CC2D1B, FEZF1	RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF]
CG_ffipsc69_promoter_n_PM_14_46_12			1	0.2	5.15E-05	HMGB1, FIS1, BAD, TSHZ3	myeloid dendritic cell activation [BP], lung development [BP], positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP]
CG_ffipsc69_promoter_n_PM_12_166_9			3	0.6	9.08E-05	UFSP1	UFM1 hydrolase activity [MF]
CG_ffipsc69_promoter_n_PM_12_169_12			2	0.4	1.68E-04	CYP7B1, CALY	clathrin light chain binding [MF], 25-hydroxycholesterol 7alpha-hydroxylase activity [MF]
CG_ffipsc69_promoter_n_PM_12_34_8			2	0.4	4.25E-05	MYO5A	regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP], insulin-responsive compartment [CC], locomotion involved in locomotory behavior [BP], secretory granule localization [BP], long-chain fatty acid biosynthetic process [BP], endoplasmic reticulum localization [BP]
CG_ffipsc69_promoter_n_PM_14_3_6			1	0.2	3.76E-05	NKX6-2	regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [BP], negative regulation of cell fate commitment [BP], central nervous system myelination [BP], regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [BP], positive regulation of cell fate commitment [BP]
CG_ffipsc69_promoter_n_PM_12_29_3			2	0.4	2.99E-05	AGA, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [MF], hydrolase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ffipsc69_promoter_n_PM_18_27_32			1	0.2	1.47E-04	POLE	base-excision repair, gap-filling [BP]
CG_ffipsc69_promoter_n_PM_18_16_47			4	0.8	2.45E-05	ENTPD4, CCR7, CALY	chemokine (C-C motif) ligand 19 binding [MF], C-C motif chemokine 19 receptor activity [MF], chemokine (C-C motif) ligand 21 binding [MF], C-C motif chemokine 21 receptor activity [MF], positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [BP], clathrin light chain binding [MF], positive regulation of immunological synapse formation [BP], chemokine (C-C motif) ligand 19 signaling pathway [BP], chemokine (C-C motif) ligand 21 signaling pathway [BP], UDP catabolic process [BP], lymphocyte migration into lymph node [BP]
CG_ffipsc69_promoter_n_PM_12_8_5			5	0.8	8.02E-05	PSMA7, PSMD5	proteasome complex [CC], regulation of cellular amino acid metabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_35_8			2	0.4	2.37E-05	TGDS, TWIST1	dTDP-glucose 4,6-dehydratase activity [MF], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP], cell proliferation involved in heart valve development [BP]
CG_ffipsc69_promoter_n_PM_14_59_18			2	0.4	6.99E-05	DNMT3A, POU4F1	S-adenosylhomocysteine metabolic process [BP], ventricular compact myocardium morphogenesis [BP], DNA methylation on cytosine within a CG sequence [BP], proprioception involved in equilibrioception [BP], habenula development [BP], C-5 methylation of cytosine [BP], S-adenosylmethioninamine metabolic process [BP], nuclear chromatin [CC], DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [MF]
CG_ffipsc69_promoter_n_PM_12_149_13			2	0.4	1.29E-04	HS3ST6	[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [MF]
CG_ffipsc69_promoter_n_PM_18_1_84			4	0.8	5.18E-05	OVOL2, FZD5	labyrinthine layer blood vessel development [BP]
CG_ffipsc69_promoter_n_PM_12_322_10			3	0.6	1.81E-04	AGT	type 2 angiotensin receptor binding [MF]
CG_ffipsc69_promoter_n_PM_18_9_42			3	0.6	3.74E-05	CLN3	lysosomal lumen pH elevation [BP], globoside metabolic process [BP], autophagic vacuole fusion [BP]
CG_ffipsc69_promoter_n_PM_14_5_13			7	1.0	7.44E-05	ULK3, GAS1	positive regulation of smoothened signaling pathway [BP], negative regulation of smoothened signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_9_9			2	0.2	1.28E-05	ABCB6, FGFR1, SSBP3	midbrain-hindbrain boundary initiation [BP], fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [BP], heme-transporting ATPase activity [MF], brain development [BP], positive regulation of anterior head development [BP], regulation of lateral mesodermal cell fate specification [BP], prechordal plate formation [BP], detoxification of cadmium ion [BP]
CG_ffipsc69_promoter_n_PM_14_30_11			3	0.6	4.86E-05	SLC19A3	water-soluble vitamin metabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_276_6			3	0.6	6.24E-05	ALDH4A1	1-pyrroline-5-carboxylate dehydrogenase activity [MF]
CG_ffipsc69_promoter_n_PM_14_83_14			2	0.4	4.86E-05	SLC30A3, DHPS	deoxyhypusine synthase activity [MF], zinc transporting ATPase activity [MF], deoxyhypusine biosynthetic process from spermidine [BP]
CG_ffipsc69_promoter_n_PM_18_19_10			1	0.2	2.91E-05	CBS	cysteine biosynthetic process via cystathionine [BP], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP], homocysteine catabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_120_10			1	0.2	2.83E-04	PRMT5, FTH1	intracellular sequestering of iron ion [BP], intracellular ferritin complex [CC], peptidyl-arginine methylation, to symmetrical-dimethyl arginine [BP], protein-arginine omega-N symmetric methyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_180_10			4	0.6	1.77E-04	TAT, BRCA1	positive regulation of histone H4-K20 methylation [BP], positive regulation of histone H3-K9 acetylation [BP], L-tyrosine:2-oxoglutarate aminotransferase activity [MF], positive regulation of histone H4-K16 acetylation [BP]
CG_ffipsc69_promoter_n_PM_12_221_7			3	0.6	6.33E-05	YWHAZ	histamine secretion by mast cell [BP]
CG_ffipsc69_promoter_n_PM_12_96_13			2	0.4	1.50E-04	CCBL1	L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], glutamine-phenylpyruvate transaminase activity [MF], L-glutamine:pyruvate aminotransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_18_10			4	0.8	1.74E-04	FAIM2, ROR2, GPX1	response to symbiotic bacterium [BP], embryonic genitalia morphogenesis [BP], regulation of neuron apoptotic process [BP]
CG_ffipsc69_promoter_n_PM_12_81_8			4	0.6	6.68E-05	CCL19	CCR7 chemokine receptor binding [MF], interleukin-12 secretion [BP], positive regulation of dendritic cell dendrite assembly [BP], CCR10 chemokine receptor binding [MF]
CG_ffipsc69_promoter_n_PM_12_211_9			2	0.4	1.14E-04	ACOX1, HBB, HSP90AA1	positive regulation of nitric oxide biosynthetic process [BP], prostaglandin metabolic process [BP]
CG_ffipsc69_promoter_n_PM_14_9_17			3	0.6	9.24E-05	IL4I1	L-amino-acid oxidase activity [MF]
CG_ffipsc69_promoter_n_PM_16_5_9			2	0.4	5.26E-05	GSK3A	negative regulation of UDP-glucose catabolic process [BP]
CG_ffipsc69_promoter_n_PM_14_82_10			4	0.8	3.56E-05	DHX15, DDX17	RNA helicase activity [MF]
CG_ffipsc69_promoter_n_PM_12_87_8			2	0.4	1.02E-05	VPS4B, PHKG1	phosphorylase kinase complex [CC], endosome to lysosome transport via multivesicular body sorting pathway [BP]
CG_ffipsc69_promoter_n_PM_12_246_7			2	0.4	6.47E-05	NTAN1	protein-N-terminal asparagine amidohydrolase activity [MF]
CG_ffipsc69_promoter_n_PM_14_31_19			2	0.4	1.24E-04	AKT1S1	cytosolic part [CC]
CG_ffipsc69_promoter_n_PM_12_83_11			3	0.4	7.05E-05	ABCC8, GNE, DHCR24	sulfonylurea receptor activity [MF], N-acylmannosamine kinase activity [MF], N-acetylglucosamine biosynthetic process [BP], N-acetylneuraminate biosynthetic process [BP], delta24-sterol reductase activity [MF], UDP-N-acetylglucosamine 2-epimerase activity [MF]
CG_ffipsc69_promoter_n_PM_12_20_6			3	0.6	2.73E-04	OPLAH	5-oxoprolinase (ATP-hydrolyzing) activity [MF]
CG_ffipsc69_promoter_n_PM_18_31_18			1	0.2	7.59E-05	PIF1, TP53, IMPAD1	release of cytochrome c from mitochondria [BP], 3'-nucleotidase activity [MF], ATP-dependent 5'-3' DNA/RNA helicase activity [MF]
CG_ffipsc69_promoter_n_PM_12_197_13			3	0.6	1.19E-04	ACHE, ENPP6	choline metabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_12_6			4	0.8	1.71E-04	TUBA1B, SORBS2, TPR, BAZ1A	positive regulation of heterochromatin assembly [BP], ACF complex [CC], structural constituent of cytoskeleton [MF], mRNA export from nucleus in response to heat stress [BP], regulation of spindle assembly involved in mitosis [BP]
CG_ffipsc69_promoter_n_PM_12_192_6			2	0.4	4.78E-05	DPM3, TOPORS, APTX	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP], DNA 5'-adenosine monophosphate hydrolase activity [MF], DNA topoisomerase binding [MF]
CG_ffipsc69_promoter_n_PM_12_97_7			3	0.6	8.06E-05	IL2, LSS, RAB3A, HPGD, TSC1, IHH	rRNA export from nucleus [BP], maintenance of presynaptic active zone structure [BP], kappa-type opioid receptor binding [MF], negative regulation of eye pigmentation [BP], lanosterol synthase activity [MF], negative regulation of lymphocyte proliferation [BP], camera-type eye photoreceptor cell fate commitment [BP], lipoxygenase pathway [BP]
CG_ffipsc69_promoter_n_PM_12_327_8			3	0.6	8.83E-05	RASIP1, ZFP36L1, PRKDC, NUDT3	diphosphoinositol polyphosphate catabolic process [BP], vasculogenesis [BP], diadenosine polyphosphate catabolic process [BP], somitogenesis [BP], T cell differentiation in thymus [BP]
CG_ffipsc69_promoter_n_PM_12_2_8			2	0.2	1.65E-04	BARD1, TH	cellular response to manganese ion [BP], terpene metabolic process [BP], epinephrine biosynthetic process [BP], tyrosine 3-monooxygenase activity [MF], dopamine biosynthetic process from tyrosine [BP], negative regulation of mRNA 3'-end processing [BP], synaptic vesicle amine transport [BP], phytoalexin metabolic process [BP], BRCA1-BARD1 complex [CC]
CG_ffipsc69_promoter_n_PM_12_229_11			2	0.4	2.84E-04	OTOP1	detection of gravity [BP]
CG_ffipsc69_promoter_n_PM_12_174_5			3	0.6	1.09E-04	CYBA, SMC1A	smooth muscle hypertrophy [BP], mitotic spindle organization [BP], cohesin core heterodimer [CC], negative regulation of glomerular filtration by angiotensin [BP]
CG_ffipsc69_promoter_n_PM_12_275_8			2	0.4	1.14E-04	NRL, NKX2-2	positive regulation of rhodopsin gene expression [BP], ventral spinal cord interneuron fate determination [BP], type B pancreatic cell fate commitment [BP]
CG_ffipsc69_promoter_n_PM_12_138_8			1	0.2	7.60E-05	ASGR2, MATN1	bone mineralization [BP], growth plate cartilage chondrocyte morphogenesis [BP]
CG_ffipsc69_promoter_n_PM_12_136_5			2	0.4	2.53E-04	GAS6, TRPC3	calcium ion transport [BP], calcium channel activity [MF], negative regulation of dendritic cell apoptotic process [BP], platelet activation [BP], virion attachment, binding of host cell surface receptor [BP], positive regulation of glomerular filtration [BP], negative regulation of interleukin-1 secretion [BP], cellular response to vitamin K [BP], calcium ion transmembrane transport [BP], negative regulation of protein import into nucleus, translocation [BP], viral entry into host cell via membrane fusion with the plasma membrane [BP], negative regulation of interleukin-6 secretion [BP], negative regulation of renal albumin absorption [BP], negative regulation of fibroblast apoptotic process [BP], negative regulation of oligodendrocyte apoptotic process [BP], hematopoietic stem cell migration to bone marrow [BP]
CG_ffipsc69_promoter_n_PM_16_10_30			5	1.0	4.65E-05	SLX4, DNA2	DNA double-strand break processing [BP], DNA replication checkpoint [BP], 5'-flap endonuclease activity [MF]
CG_ffipsc69_promoter_n_PM_12_273_6			2	0.4	2.23E-05	INTS1, PDGFB	negative regulation of phosphatidylinositol biosynthetic process [BP], superoxide-generating NADPH oxidase activator activity [MF], positive regulation of hyaluronan biosynthetic process [BP], paracrine signaling [BP], metanephric glomerular endothelium development [BP], metanephric glomerular mesangial cell development [BP], positive regulation of glomerular filtration [BP], cellular response to mycophenolic acid [BP], U2 snRNA 3'-end processing [BP], positive regulation of metanephric mesenchymal cell migration [BP], positive regulation of glomerular mesangial cell proliferation [BP], positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_219_12			6	1.0	5.34E-05	IMPG2, GNE, HAPLN4	UDP-N-acetylglucosamine metabolic process [BP], hyaluronic acid binding [MF]
CG_ffipsc69_promoter_n_PM_16_23_20			5	1.0	4.98E-05	HEYL, GJC1, JUP	atrioventricular valve morphogenesis [BP], cell-cell junction assembly [BP]
CG_ffipsc69_promoter_n_PM_16_30_18			5	1.0	7.21E-05	BAD	cellular response to chromate [BP]
CG_ffipsc69_promoter_n_PM_12_212_10			5	0.8	1.67E-04	NRP1, TGFB3	growth factor binding [MF], salivary gland morphogenesis [BP]
CG_ffipsc69_promoter_n_PM_12_173_7			3	0.6	1.34E-04	NTSR2	G-protein coupled neurotensin receptor activity [MF]
CG_ffipsc69_promoter_n_PM_12_231_14			2	0.4	1.49E-04	NUDT3, BAIAP2L1, RABAC1	diphosphoinositol polyphosphate catabolic process [BP], proline-rich region binding [MF], diadenosine polyphosphate catabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_325_9			3	0.6	4.21E-05	CHCHD4, CACTIN	protein import into mitochondrial intermembrane space [BP], negative regulation of type I interferon-mediated signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_196_11			4	0.8	2.90E-05	CHCHD4, LIF	protein import into mitochondrial intermembrane space [BP], positive regulation of histone H3-K27 acetylation [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], positive regulation of protein localization to nucleus [BP], leukemia inhibitory factor receptor binding [MF]
CG_ffipsc69_promoter_n_PM_14_57_22			6	1.0	1.49E-05	ESD, SLC4A5	sodium:bicarbonate symporter activity [MF], formaldehyde catabolic process [BP], S-formylglutathione hydrolase activity [MF], methylumbelliferyl-acetate deacetylase activity [MF]
CG_ffipsc69_promoter_n_PM_12_268_7			1	0.2	3.77E-04	TNFSF18	T cell proliferation involved in immune response [BP]
CG_ffipsc69_promoter_n_PM_12_118_10			3	0.6	5.09E-05	EIF4E, APLN, AURKAIP1	eukaryotic initiation factor 4G binding [MF], apelin receptor binding [MF], negative regulation of mitosis [BP]
CG_ffipsc69_promoter_n_PM_18_5_78			5	0.8	7.97E-05	RTKN, CDC42EP4, FMNL3	Rho GTPase binding [MF], GTP-Rho binding [MF]
CG_ffipsc69_promoter_n_PM_18_13_16			1	0.2	5.69E-05	YARS, FGF8, NFS1	cell migration involved in mesendoderm migration [BP], interleukin-8 receptor binding [MF], tyrosyl-tRNA aminoacylation [BP], iron incorporation into metallo-sulfur cluster [BP], tyrosine-tRNA ligase activity [MF], cysteine desulfurase activity [MF]
CG_ffipsc69_promoter_n_PM_12_14_6			2	0.4	3.18E-05	MYH11, SLC38A7, ADAT1, FERMT2	tRNA-specific adenosine deaminase activity [MF], stress fiber [CC], L-methionine transmembrane transporter activity [MF], L-leucine transmembrane transporter activity [MF]
CG_ffipsc69_promoter_n_PM_14_2_7			6	1.0	7.48E-05	VWF, ADA, STAT5B	Peyer's patch development [BP], liver development [BP], cytoplasmic membrane-bounded vesicle lumen [CC]
CG_ffipsc69_promoter_n_PM_12_21_13			3	0.6	1.33E-05	SLC23A1, MAD1L1	mitotic telophase [BP], dehydroascorbic acid transport [BP]
CG_ffipsc69_promoter_n_PM_16_46_9			4	0.8	6.59E-05	DMC1, INSL3, PSME2	oocyte maturation [BP], cellular nitrogen compound metabolic process [BP]
CG_ffipsc69_promoter_n_PM_14_52_8			2	0.4	8.14E-05	SCIMP, GCH1	tetraspanin-enriched microdomain [CC], uropod membrane [CC], GTP cyclohydrolase I activity [MF], regulation of lung blood pressure [BP], tetrahydrofolate biosynthetic process [BP], 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
CG_ffipsc69_promoter_n_PM_12_19_8			3	0.6	1.81E-04	MDC1	FHA domain binding [MF]
CG_ffipsc69_promoter_n_PM_16_41_10			3	0.6	1.54E-05	UBQLN4, HAAO	nuclear proteasome complex [CC], 3-hydroxyanthranilate 3,4-dioxygenase activity [MF], cytosolic proteasome complex [CC]
CG_ffipsc69_promoter_n_PM_12_145_15			2	0.4	9.16E-05	HAND1, ARAP1, APOD	embryonic heart tube formation [BP], negative regulation of lipoprotein lipid oxidation [BP], actin filament reorganization involved in cell cycle [BP], negative regulation of T cell migration [BP], negative regulation of cytokine production involved in inflammatory response [BP]
CG_ffipsc69_promoter_n_PM_16_12_27			2	0.4	8.07E-05	AIFM2	electron-transferring-flavoprotein dehydrogenase activity [MF]
CG_ffipsc69_promoter_n_PM_14_65_5			3	0.6	3.06E-05	LONP1	mitochondrial heavy strand promoter anti-sense binding [MF], oxidation-dependent protein catabolic process [BP], DNA polymerase binding [MF], mitochondrial light strand promoter anti-sense binding [MF]
CG_ffipsc69_promoter_n_PM_12_256_5			2	0.4	6.86E-05	RAB3A, RC3H1	maintenance of presynaptic active zone structure [BP], regulation of synaptic vesicle fusion to presynaptic membrane [BP], sensory perception of touch [BP], negative regulation of germinal center formation [BP]
CG_ffipsc69_promoter_n_PM_12_32_9			2	0.4	8.28E-05	RBBP7, CDC25C	DNA replication [BP]
CG_ffipsc69_promoter_n_PM_12_144_10			3	0.6	2.10E-05	PODXL, DPYS	uracil binding [MF], uracil catabolic process [BP], thymine catabolic process [BP], thymine binding [MF], regulation of microvillus assembly [BP]
CG_ffipsc69_promoter_n_PM_12_184_10			3	0.6	6.64E-05	SYT6, OSBPL3	perinuclear endoplasmic reticulum [CC]
CG_ffipsc69_promoter_n_PM_14_6_5			2	0.4	2.82E-05	ASPDH	aspartate dehydrogenase activity [MF]
CG_ffipsc69_promoter_n_PM_12_264_6			2	0.4	1.06E-04	PAIP2B	negative regulation of translational initiation [BP]
CG_ffipsc69_promoter_n_PM_16_9_21			3	0.6	1.88E-05	MST1R	macrophage colony-stimulating factor signaling pathway [BP], macrophage colony-stimulating factor receptor activity [MF]
CG_ffipsc69_promoter_n_PM_14_72_19			4	0.8	8.00E-06	C6orf15	collagen V binding [MF]
CG_ffipsc69_promoter_n_PM_12_298_9			2	0.4	7.66E-05	ZFP64, SREBF1, ZNF846, SIN3A, AHDC1	DNA binding [MF], response to glucose stimulus [BP], aging [BP], regulation of heart rate by chemical signal [BP], positive regulation of chromatin silencing [BP], negative regulation of protein localization to nucleus [BP], response to methylglyoxal [BP], protein deacetylation [BP], sterol response element binding [MF], negative regulation of histone H3-K27 acetylation [BP]
CG_ffipsc69_promoter_n_PM_18_7_22			4	0.8	4.46E-05	CLTB	clathrin coat of coated pit [CC]
CG_ffipsc69_promoter_n_PM_12_289_6			2	0.4	7.55E-05	PTGR1	2-alkenal reductase [NAD(P)] activity [MF], 15-oxoprostaglandin 13-oxidase activity [MF], 13-prostaglandin reductase activity [MF]
CG_ffipsc69_promoter_n_PM_16_19_19			4	0.8	5.74E-05	YES1, CD24, TNFRSF13C	T cell costimulation [BP]
CG_ffipsc69_promoter_n_PM_18_29_18			2	0.4	4.36E-05	B4GALT5, B3GNT1, HEXA	keratan sulfate metabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_181_14			4	0.8	4.50E-05	SLC35B4, STAR	UDP-xylose transport [BP], cellular response to luteinizing hormone stimulus [BP], UDP-xylose transmembrane transporter activity [MF]
CG_ffipsc69_promoter_n_PM_12_283_20			4	0.8	1.20E-04	PLTP, SRD5A2, CYP17A1	vitamin E biosynthetic process [BP], androgen biosynthetic process [BP], response to acetate [BP], androgen metabolic process [BP]
CG_ffipsc69_promoter_n_PM_16_13_16			2	0.4	3.86E-05	TK1	fetal process involved in parturition [BP]
CG_ffipsc69_promoter_n_PM_12_208_10			4	0.8	4.70E-05	MICALL2	actin filament bundle [CC]
CG_ffipsc69_promoter_n_PM_12_243_5			1	0.2	2.89E-04	CYBA	smooth muscle hypertrophy [BP], negative regulation of glomerular filtration by angiotensin [BP]
CG_ffipsc69_promoter_n_PM_16_47_9			1	0.2	4.73E-05	LATS2, NUP62, RACGAP1	cytokinesis, actomyosin contractile ring assembly [BP], cytokinesis, initiation of separation [BP], hormone-mediated signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_14_17_7			4	0.8	7.04E-05	DEDD2, BID	extrinsic apoptotic signaling pathway via death domain receptors [BP], positive regulation of extrinsic apoptotic signaling pathway [BP]
CG_ffipsc69_promoter_n_PM_12_48_12			5	0.8	5.58E-05	GHSR, ACVR1, ACOX2	growth hormone secretagogue receptor activity [MF], 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity [MF], positive regulation of fatty acid metabolic process [BP], peptide hormone binding [MF]
CG_ffipsc69_promoter_n_PM_12_278_10			1	0.2	1.41E-04	WNK3	positive regulation of rubidium ion transport [BP], positive regulation of rubidium ion transmembrane transporter activity [BP]
CG_ffipsc69_promoter_n_PM_12_255_6			3	0.6	4.39E-05	BCAT2	isoleucine catabolic process [BP]
CG_ffipsc69_promoter_n_PM_12_302_21			1	0.2	3.71E-05	TXNRD2, NUDT14, GHRH	response to oxygen radical [BP], growth hormone-releasing hormone receptor binding [MF], UDP-sugar diphosphatase activity [MF]
CG_ffipsc69_promoter_n_PM_12_80_5			3	0.6	4.32E-05	HID1	response to brefeldin A [BP], extrinsic to Golgi membrane [CC]
CG_ffipsc69_promoter_n_PM_12_251_12			3	0.6	1.73E-05	EIF2AK2	evasion or tolerance by virus of host immune response [BP]
CG_ffipsc69_promoter_n_PM_16_43_16			4	0.8	1.28E-04	AURKB, FHIT, CLASP1	mitotic prometaphase [BP], centrosomal corona [CC], cortical microtubule cytoskeleton [CC], bis(5'-adenosyl)-triphosphatase activity [MF], condensed chromosome, centromeric region [CC], microtubule anchoring [BP]
CG_ffipsc69_promoter_n_PM_18_35_27			4	0.8	6.38E-05	FLT4, DCUN1D3, ESR2, DLG4, GNB2L1	negative regulation of cell growth [BP], protein phosphatase binding [MF]
CG_ffipsc69_promoter_n_PM_12_287_13			4	0.8	6.12E-05	TAF7	spermine transport [BP]
CG_ffipsc69_promoter_n_PM_12_245_8			2	0.4	9.26E-05	GEMIN5, SHPK	cellular response to interleukin-13 [BP], snRNA binding [MF], sedoheptulokinase activity [MF]
CG_ffipsc69_promoter_n_PM_12_270_5			1	0.2	5.00E-05	MMAB	cob(I)yrinic acid a,c-diamide adenosyltransferase activity [MF]
CG_ffipsc69_promoter_n_PM_12_78_16			2	0.4	1.04E-04	DUSP16, DUSP7	inactivation of MAPK activity [BP], MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], negative regulation of MAP kinase activity [BP], MAPK export from nucleus [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF]
CG_ffipsc69_promoter_n_PM_12_262_10			2	0.4	1.17E-04	RTN4	regulation of branching morphogenesis of a nerve [BP]